InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,709.54
(
0.01%
)
US TECH 100
19,328.40
(
0.40%
)
Dow Jones
42,196.52
(
0.09%
)
Brent Oil
74.62
(
0.26%
)
Bitcoin
60,487.22
(
-0.57%
)
Post# of 253266
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 47
Posts 4710
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: ronpopeil post# 199321

Wednesday, 01/27/2016 12:30:43 PM

Wednesday, January 27, 2016 12:30:43 PM

Post# of 253266
TRIL

I'm sort of indifferent. I wouldn't want TRIL to divert limited resources from the CD47 drug. I also hope they continue to remain focused on partnering w other mroe advanced drugs down the road and don't get preoccupied w an in house cocktail. OTOH it's nice to have a pipeline and this one at first glance seems to complement the drug they have nicely. I wonder if they have some preclinical data already on combo w their own drug - wouldn't that be nice
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up